Drawing for BIGFINITE

USPTO serial 87338248

BIGFINITE

Reviewed by CopyMark Law Group

Reg. 5467091Status 702Registered
Filing date
Status date
Registration date
May 15, 2018
Examiner
JENKINS, KEISHA MONIQUE HARD
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with BIGFINITE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Leigh Ann Lindquist

Leigh Ann Lindquist SUGHRUE MION, PLLC2000 PENNSYLVANIA AVENUE NW, SUITE 9000Washington, DC 20006United States

Goods and services

ClassDescriptionStatusFirst use
009Providing downloadable cloud based software for data management and processing in relation to the creation and production of pharmaceuticals in order to improve conformity with regulatory requirements and licensing procurementACTIVEDec 1, 2015
042Software as a service (SAAS) featuring software for use by others for data storage, analysis, process, control and management; Software as a service (SAAS) featuring software for use by others for the acquisition, record, visualization and knowledge generation of industrial processes data; Providing temporary use of Online non-downloadable software for the provision of data management, process, analysis and control via website; cloud computing services, namely cloud hosting provider services; Consulting services in the field of cloud computing; Computer programming services for commercial analysis and reporting; advanced analytic services related to computers in the nature of computer systems analysis; Big data related services, namely providing temporary use of online non-downloadable software for the management, storage, process, analysis and control of data; Advanced product research in the field of artificial intelligence; software development services featuring development of artificial intelligence; data analysis services for the identification of issues and inefficiencies within the pharmaceutical manufacturing processes; data analysis services for lowering manufacturing-quality issues in the field of biopharmaceuticals; analysis services of pharmaceutical manufacturing data and information provided by users through online software; consultancy relating to the pharmaceutical research; conducting of quality control evaluations and assessments of the deployed solutions, namely the implementation and customization of software applications, and the installed Internet of Things components developed by the company; Testing, authentication and quality control of the deployed solutions, namely the implementation and customization of software applications, and the installation of Internet of Things components services; Development of computer software for the compilation and analysis of data designed for use in the control of manufacturing processes; Design and development of computer software for the manufacturing industries; analysis and testing services of the installed Internet of Things components developed by the company and the big data projects performed through the cloud platform supplied by the company for the pharmaceutical and biotechnological industry to assure compliance with industry standards; Advisory services in the field of product development and quality improvement of pharmaceuticals provided through online software and software as a service; programming and development of computer software for data processing and analysis; software as a service provided on a cloud basis that allows users to provide information and data in the field of industrial processes through online website ensuring source traceability and changes-track control; providing temporary use of online-non-downloadable software for data management and processing in relation to the creation and production of pharmaceuticals in order to improve conformity with regulatory requirements and licensing procurement; Software as a service (SAAS) services featuring software for providing data analysis reports to users in the field of pharmaceutical and biotechnology; Software as a service (SAAS) services consisting of hosting of software programs to input manufacturing data by users and allow them to obtain analysis results identifying manufacturing inefficiencies; Software as a service (SAAS) featuring software for collecting, organizing, transmitting, receiving, sharing, analyzing and storing electronic data, text and graphics via communications networks; Software as a service (SAAS) featuring software for generating reports regarding to analysis of data, inefficiency issues, improvement possibilities and control of quality-issues; designing interactive computer software programs in the nature of productivity programs, database programs, reporting programs, graphics programs, analytical programs and global network programs for others; Software as a service (SAAS) platform featuring computer software for extracting manufacturing raw data information from the biopharmaceutical industry for use in the decision making processACTIVEOct 20, 2014

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 28, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Aug 28, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Aug 26, 2025EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Mar 17, 2025PR23POST REGISTRATION ACTION MAILED - SEC. 8 & 15—
Mar 4, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 30, 2024E815TEAS SECTION 8 & 15 RECEIVED—
May 15, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 1, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 1, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 15, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 27, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 27, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 7, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 25, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 12, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 12, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 12, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 26, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 26, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 26, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 6, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 6, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 6, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 30, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 11, 2017DOCKASSIGNED TO EXAMINER—
Mar 13, 2017AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Mar 10, 2017ALIEASSIGNED TO LIE—
Feb 23, 2017PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Feb 23, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Feb 22, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 20, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance